Related Experiment Video
Updated: Dec 30, 2025

Yeast As a Chassis for Developing Functional Assays to Study Human P53
Published on: August 4, 2019
Mutant p53 on the Path to Metastasis
Qiaosi Tang1, Zhenyi Su2, Wei Gu2
1Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA; Herbert Irving Comprehensive Cancer Center, Columbia University, New York, NY 10032, USA.
Abstract:
Metastasis contributes to the vast majority of cancer-related mortality. Regulatory mechanisms of the multistep invasion-metastasis cascade are being unraveled. TP53 is the most frequently mutated gene across human cancers. Accumulating evidence has shown that mutations of TP53 not only lead to loss of function or dominant negative effects, but also promotes a gain of function. Specifically, gain of function mutant p53 promotes cancer cell motility, invasion, and metastasis. Here, we summarize the mechanisms and functions of mutant p53 that foster metastasis in different types of cancers. We also discuss the prognostic value of mutant p53 and current status of therapeutic strategies targeting mutant p53. Future studies will shed light on discovering novel mechanisms of mutant p53-driven cancer metastasis and developing innovative therapeutics to improve clinical outcomes in patients harboring p53 mutations.
Insights
Mutant p53, a common cancer gene mutation, actively promotes cancer cell spread and metastasis. Understanding these mechanisms is key to developing new therapies for patients with TP53 mutations.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Research
Background:
- Metastasis is the primary cause of cancer mortality.
- The tumor suppressor gene TP53 is frequently mutated in human cancers.
- TP53 mutations can result in loss-of-function, dominant-negative, or gain-of-function effects.
Purpose of the Study:
- To summarize the mechanisms and functions of mutant p53 in promoting cancer metastasis.
- To discuss the prognostic implications of mutant p53.
- To review current therapeutic strategies targeting mutant p53.
Main Methods:
- Literature review and synthesis of existing research on mutant p53 and metastasis.
- Analysis of studies detailing gain-of-function mechanisms of mutant p53.
- Examination of data on the prognostic value and therapeutic targeting of mutant p53.
Main Results:
- Gain-of-function mutant p53 actively enhances cancer cell motility, invasion, and metastasis.
- Mutant p53 plays a significant role in fostering metastasis across various cancer types.
- Evidence highlights the prognostic significance of TP53 mutations.
Conclusions:
- Mutant p53 is a critical driver of cancer metastasis through specific gain-of-function mechanisms.
- Targeting mutant p53 holds therapeutic potential for improving patient outcomes.
- Further research is needed to uncover novel mechanisms and develop innovative treatments.
Related Concept Videos
Abnormal Proliferation
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
DNA Damage can Stall the Cell Cycle
DNA Damage Can Stall the Cell Cycle
mTOR Signaling and Cancer Progression
The mTOR pathway or the...

